83 /100
CRITICAL RISK
Score updated Jul 14, 2026

ADGM — Adagio Medical Holdings, Inc. Dilution Risk Tracker

Track ADGM dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track ADGM — Get alerts when the score changes →

As of July 14, 2026, Adagio Medical Holdings, Inc. (ADGM) has a DilutionWatch DilutionScore of 83/100, rated CRITICAL dilution risk. Adagio Medical Holdings, Inc. has a market capitalization of $16.08M, 22.21M shares outstanding, 24 institutional holders tracked. Key dilution vectors include ATM program capacity of $31.82M, approximately 6 months of cash runway.

Source: DilutionWatch (dilutionwatch.com) — data updated daily from SEC EDGAR filings. Not financial advice.

📊 Score Breakdown

📋 Offering Ability
72
💰 Cash Runway
65
📊 Float Risk
77
⚠️ Warrant Exposure
40
🔄Convertible Debt

🌦️ Dilution Forecast

⛈️
Warning
High probability of dilution event
48%
🔁 Convertible Conversion 60%
• Major convertible overhang: 142% potential dilution
• Convertible risk score very high (85/100)
🔄 Reverse Split 40%
• 50-day avg $1.12 approaching $1 threshold
• 6 months cash with weak price
💰 Capital Raise 33%
• Under 12 months cash (6mo)
• Active ATM program with $32M remaining capacity
🔔 Track ADGM — Get forecast alerts →

💹 Market Data

Market Cap$16.08M
Shares Outstanding22.21M
Float4.81M
Cash$12.91M
Debt$22.87M
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↑ 9.5% shares (2026Q1 vs prior)
24 institutional holders · 19.50M shares
#1 PERCEPTIVE ADVISORS LLC 13.66M shares
#2 Sio Capital Management, LLC 1.29M shares
#3 ADAGE CAPITAL PARTNERS GP, L.L.C. 1.26M shares
+ 17 more holders Sign up free to view →

📉 Short Interest

Short Interest60.2K
Days to Cover1.0
% of Float1.2%
FINRA data as of Jun 30, 2026

📁 Recent SEC Activity

xbrl XBRL CONVERTIBLE Mar 31, 2026
xbrl XBRL WARRANT Dec 31, 2025
EFFECT EFFECT Apr 03, 2026
EFFECT EFFECT Apr 03, 2026
424B3 ATM Mar 27, 2026
Full SEC filing analysis available with free account

📰 Recent News

No recent news

📋 What This Means for ADGM Shareholders

Adagio Medical Holdings, Inc. (ADGM) carries a DilutionScore of 83/100, placing it in the Critical dilution risk tier — the highest category tracked by DilutionWatch. Companies at this level typically have active capital-raising programs, compressed cash runway, or a combination of dilution vectors that together represent meaningful downside risk to share count. As of July 14, 2026, this score reflects real-time data pulled directly from SEC EDGAR filings.

ADGM has an active ATM (at-the-market) program with $31.8M remaining capacity. ATM programs allow companies to sell shares continuously into the open market through a broker-dealer — without announcing a secondary offering. This creates a silent but steady source of share dilution that shows up in quarterly share count increases rather than a discrete offering event. Cash runway is a key watch item: ADGM has approximately 6 months of runway at current burn rate. Companies with less than 18 months of runway are statistically more likely to file new shelf registrations or ATM programs within the next two quarters. DilutionWatch monitors SEC 10-Q filings to update this estimate each quarter.

DilutionWatch tracks over 25 SEC filing types for ADGM in real-time, scanning EDGAR every 60 seconds. The DilutionWatch screener shows real-time score changes for ADGM alongside comparable critical-risk stocks. Not financial advice — this analysis is for informational purposes only.

How ATM Offerings Work →
Track ADGM Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking ADGM — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

🔗 Related Stocks — CRITICAL Risk

Other CRITICAL dilution risk stocks tracked by DilutionWatch with similar profiles:

Browse all 7,800+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
🔬 More Research for ADGM
📊 ADGM FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 ADGM Signal Convergence & Dark Pool Activity — StonkWhisper 📄 ADGM Dilution Risk Analysis — Full In-Depth Report

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.